Skip to Content

Vanderbilt-Ingram Cancer CenterVanderbilt-Ingram Cancer Center

 

VICC toll-free number 1-877-936-8422

Clinical Trials for Other

19 Open Trials

Trial Type Protocol No. &
Open Date
Summary

Basic Science

Miscellaneous

VICCPED1544

12/14/2015

Michigan Acute Graft-versus-Host Disease International Consortium (MAGIC): A Database and Biorepository

Basic Science

Miscellaneous

VICCMD1564

11/23/2015

Acquisition and Research Use of Biospecimens in Cancer Patients

Basic Science

Miscellaneous

VICCBIO0478

03/31/2004

Donating Tissues for Research

Diagnostic

Miscellaneous

VICCSAR1458

04/22/2015

F18-FES PET/CT Imaging of Desmoid Tumors

Other

Miscellaneous

COGAPEC14B1

01/20/2016

The Project: EveryChild Protocol: A Registry, Eligibility Screening, Biology and Outcome Study

Other

Miscellaneous

VICCMEL15138

06/23/2015

Survivorship in Patients Receiving Immune Checkpoint Inhibitors

Other

Lung
Miscellaneous
Small Cell

VICCMD1494

10/31/2014

Specimen Collection under Clinical Protocol 06-C-0213 for Generation of Patient-Derived Models

Other

Miscellaneous

VICCPED0710

03/16/2007

Long Term Effects for Childhood Cancer Survivors

Prevention

Other

CTSUHNE1311-M

09/03/2013

A Randomized, Placebo Controlled Phase II Trial of Afatinib (BIBW2992) as Adjuvant Therapy Following Chemoradiation in Patients with Head and Neck Squamous Cell Carcinoma at High Risk of Recurrence

Supportive Care

Miscellaneous

VICCREACH1525

05/11/2015

Navigated Early Survivorship Transition (NEST) Project

Supportive Care

Miscellaneous

VICCBMT14119

01/21/2015

A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Multi-Center Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of GS-5806 in Hematopoietic Cell Transplant (HCT) Recipients with Respiratory Syncytial Virus (RSV) Infection of the Lower Respiratory Tract

Supportive Care

Miscellaneous

VICCBMT14118

01/21/2015

A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Multi-Center Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of GS-5806 in Hematopoietic Cell Transplant (HCT) Recipients with Respiratory Syncytial Virus (RSV) Infection of the Upper Respiratory Tract

Treatment

Miscellaneous

VICCPHI1502

06/20/2016

A phase I/II open-label, dose escalation study to investigate the safety, pharmacokinetics, pharmacodynamics and clinical activity of GSK525762 in subjects with NUT midline carcinoma (NMC) and other cancers

Treatment

Lymphoma
Miscellaneous

VICCPHI1616

06/08/2016

A Phase 1 Open-Label Study of the Safety, Tolerability and Efficacy of KPT-9274, a Dual Inhibitor of PAK4 and NAMPT, in Patients with Advanced Solid Malignancies or Non-Hodgkin's Lymphoma

Treatment

Colon
Head/Neck
Liver
Lung
Miscellaneous
Neuro-Oncology
Rectal
Sarcoma
Thyroid

VICCMD15110

04/05/2016

A Phase II Basket Study of the Oral TRK Inhibitor LOXO-101 in Subjects with NTRK Fusion-Positive Tumors

Treatment

Other

ECOGEAY131-M

07/16/2015

Molecular Analysis for Therapy Choice

Treatment

Other

INCBBRE268-M

11/21/2014

INCB 18424-268 A Randomized, Double-Blind, Phase 2 Study of Ruxolitinib or Placebo in Combination with Capecitabine in Subjects with Advanced or Metastatic HER2-negative Breast Cancer (

Treatment

Other

CTSUBREA011106-M

11/01/2014

BRE A011106: ALTernate approaches for clinical stage II or III Estrogen Receptor positive breast cancer NeoAdjuvant TrEatment (ALTERNATE) in postmenopausal women: a phase III study

Treatment

Other

CTSUMM1A11-M

02/12/2014

MM E1A11: Randomized Phase III Trial of Bortezomib, LENalidomide and Dexamethasone (VRd) Versus Carfilzomib, Lenalidomide and Dexamethasone (CRd) Followed by Limited or Indefinite DURation Lenalidomide MaintenANCE in Patients with Newly Diagnosed Symptomatic Multiple Myeloma (ENDURANCE)